On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...